Evidence map›Paper›PMID 33434785›Full record

ArticleTuberculosis (Edinburgh, Scotland)2021

Immune variations throughout the course of tuberculosis treatment and its relationship with adrenal hormone changes in HIV-1 patients co-infected with Mycobacterium tuberculosis.

María Belén Vecchione, Matías Tomás Angerami, Guadalupe Verónica Suarez, Gabriela Turk, Natalia Laufer, Graciela Ben, Diego Ameri, Diego Gonzalez, Laura M Parodi, Luis D Giavedoni and 5 more

Open access · greenAbstract read
In one paragraph

Article in Tuberculosis (Edinburgh, Scotland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

María Belén VecchioneUniversidad de Buenos Aires. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS). Facultad de Medicina, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: mvecchione@fmed.uba.ar.
Matías Tomás AngeramiUniversidad de Buenos Aires. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS). Facultad de Medicina, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: m_angerami@hotmail.com.
Guadalupe Verónica SuarezUniversidad de Buenos Aires. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS). Facultad de Medicina, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: suarez_guadalupe@hotmail.com.
Gabriela TurkUniversidad de Buenos Aires. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS). Facultad de Medicina, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: gturk@fmed.uba.ar.
Natalia LauferUniversidad de Buenos Aires. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS). Facultad de Medicina, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: nlaufer@fmed.uba.ar.
Graciela BenHospital Juan A. Fernández. Buenos Aires, Argentina. Electronic address: graciela_ben@yahoo.com.ar.
Diego AmeriHospital Juan A. Fernández. Buenos Aires, Argentina. Electronic address: diegoameri@hotmail.com.
Diego GonzalezUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica. Cátedra de Bioquímica Clínica I, Ciudad Autónoma de Buenos Aires, Argentina; Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Fisiopatología y Bioquímica Clínica (INFIBIOC), Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: diegojgz@hotmail.com.
Laura M ParodiHost-Pathogen Interactions Program, Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, 78227, USA. Electronic address: lparodi@txbiomed.org.
Luis D GiavedoniHost-Pathogen Interactions Program, Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, 78227, USA. Electronic address: lgiavedoni@txbiomed.org.
Patricia MaidanaUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica. Cátedra de Bioquímica Clínica I, Ciudad Autónoma de Buenos Aires, Argentina; Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Fisiopatología y Bioquímica Clínica (INFIBIOC), Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: pnamaidana@gmail.com.
Bibiana FabreUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica. Cátedra de Bioquímica Clínica I, Ciudad Autónoma de Buenos Aires, Argentina; Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Fisiopatología y Bioquímica Clínica (INFIBIOC), Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: brfabre2000@yahoo.com.ar.
Viviana MeschUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica. Cátedra de Bioquímica Clínica I, Ciudad Autónoma de Buenos Aires, Argentina; Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Instituto de Fisiopatología y Bioquímica Clínica (INFIBIOC), Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: vmesch@yahoo.com.ar.
Omar SuedÁrea de Investigaciones Médicas, Fundación Huésped, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: omar.sued@huesped.org.ar.
Maria Florencia QuirogaUniversidad de Buenos Aires. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS). Facultad de Medicina, Ciudad Autónoma de Buenos Aires, Argentina. Electronic address: fquiroga@fmed.uba.ar.
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad de Buenos Aires · ARHospital Fernández · ARTexas Biomedical Research Institute · USFundación Huésped · AR

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
NIH HHS P51 OD011133
6 · The paper itself

Abstract

HIV infection is a major risk factor predisposing for Mycobacterium tuberculosis infection and progression to active tuberculosis (TB). As host immune response defines the course of infection, we aimed to identify immuno-endocrine changes over six-months of anti-TB chemotherapy in HIV+ people. Plasma levels of cortisol, DHEA and DHEA-S, percentages of CD4

Indexed as

Adrenal Cortex HormonesAdultAntitubercular AgentsBiomarkersCoinfectionCytokinesDehydroepiandrosteroneDehydroepiandrosterone SulfateFemaleHIV-1HIV InfectionsHost-Pathogen InteractionsHumansHydrocortisoneMaleMiddle AgedAdrenal Cortex HormonesAntitubercular AgentsBiomarkersCytokinesDehydroepiandrosteroneDehydroepiandrosterone SulfateHydrocortisoneAdrenal hormonesCytokinesHIV-TB coinfectionProspective studyRegulatory T cellsTuberculosis

Identifiers

PMID33434785
PMCPMC7965356
OpenAlexW3118533557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.